1 / 31

KoriAnne Elkins Galler, M.D. Resident’s Day May 30 th, 2008

A Comparison between Fluorescein Angiography and Optical Coherence Tomography Findings in Patients with Clinically Significant Macular Edema. KoriAnne Elkins Galler, M.D. Resident’s Day May 30 th, 2008. Introduction.

tallison
Télécharger la présentation

KoriAnne Elkins Galler, M.D. Resident’s Day May 30 th, 2008

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. A Comparison between Fluorescein Angiography and Optical Coherence Tomography Findings in Patients with Clinically Significant Macular Edema KoriAnne Elkins Galler, M.D. Resident’s Day May 30th, 2008

  2. Introduction • Macular edema is the most common cause of decreased visual acuity and quality of life in diabetic patients • Slit lamp biomicroscopy is the gold standard for diagnosis based on the ETDRS criteria • Laser photocoagulation is the mainstay of treatment for CSME

  3. Introduction • Vascular leakage can be qualitatively measured with fluorescein angiography (FA) • Provides guidance for application of focal laser • Leakage can be present without clinical evidence of edema • Optical coherence tomography (OCT) is a non-invasive way to calculate macular thickening and demonstrate retinal swelling

  4. Introduction • Several authors have established a correlation between FA leakage and abnormal macular thickness or retinal swelling on OCT • However, these studies have several limitations • Timing of FA and OCT data • Inclusion of only horizontal and vertical meridians for comparison • Otani T, Kishi S. Correlation between Optical Coherence Tomography and Fluorescein Angiography Findings in Diabetic Macular Edema. Ophthalmology 2007;114 Kang SW, Park CY, Ham DI: The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. Am J Ophthalmol 2004;137:313–322. Özdek SC, Erdinç MA, Gürelik G, Aydın B, Bahçeci U, Hasanreisog B. Optical Coherence Tomographic Assessment of Diabetic Macular Edema: Comparison with Fluorescein Angiographic and Clinical Findings. Ophthalmologica 2005;219:86–92

  5. Introduction • OCT has the potential to improve clinic efficiency • In some places, OCT is being used in placed of FA • In order for OCT to supplant FA, it must be able to reliably detect leakage and provide valuable information for treatment and follow-up

  6. Purpose • To evaluate the correlation between fluorescein leakage and optical coherence tomography (OCT) abnormalities in diabetic patients with clinically significant macular edema (CSME)

  7. Methods • Retrospective review of 74 eyes of 48 patients with a diagnosis of CSME • All patients that had fluorescein angiography (FA) and OCT testing on the same day were reviewed

  8. Methods • Treatment-naïve and treated patients (laser, intravitreal injection, or vitrectomy) were included in this study

  9. Methods • Fluorescein angiograms were graded by a single physician in a masked fashion • OCTs were read independently of the FAs by a second masked physician

  10. Methods: Fluorescein Angiography • For each eye, digitized early-phase and late-phase FA images were reviewed • Early: 1-2 minutes post-injection • Late: 5-10 minutes post-injection • Images were overlain with a modified ETDRS grid and type of leakage recorded

  11. Methods: Fluorescein Angiography

  12. Grades of FA leakage

  13. Methods: OCT Analysis • OCT was performed on a Zeiss OCT3 • 6.0-mm scans in 6 meridians (every 30 degrees) for each study eye • A digitized grid was created for the radial OCT scans to correspond to the same areas as the ETDRS grid

  14. Methods: OCT Analysis

  15. Methods: OCT Types

  16. Methods: Comparison of FA’s to OCT’s

  17. Methods: OCT Map Analysis • The standard macular thickness map was used to record the thickness in 9 standard subfields • Values of > 250 microns for central foveal thickness and > 300 microns for other subfields were considered abnormal

  18. Results: Baseline Characteristics 74 eyes of 48 patients the study

  19. Results: Patterns of Leakage Normal Focal Mixed Diffuse CME

  20. FA/OCT Correlation 74 Eyes x 9 zones per eye = 666 zones Only 42% of zone-by-zone comparisons had both an abnormal FA and OCT

  21. Results: Abnormal OCT’s by FA Grade

  22. Concordance of FA & OCT • A total of 666 comparisons were made between FA and OCT zones • 386 (58%) showed consistent findings • 233 (35%) had an abnormal FA with a normal OCT in all 3 subscans • 47 (7.1%) resulted in a normal FA with an abnormal OCT in at least one scan • Cohen’s kappa of 0.1673 (poorly concordant)

  23. Macular Thickness Correlation & Distribution

  24. Discussion • Of the 280 (42%) comparisons that resulted in a mis-match between FA and OCT • 233 (35%) with abnormal FA and a normal OCT • Only 47 (7.1%) instances with a normal FA but some abnormality detected on the OCT • Additionally, in 35% of patients OCT thickness measurements were normal despite FA leakage

  25. Discussion • This suggests that there is a large subset of patients that will have leakage detected on FA but no comparable OCT changes or increased macular thickness

  26. Discussion • Two possibilities to account for this difference • First, these patients may still have a relatively healthy retinal pigment epithelium • Able to pump out the additional fluid without leading to retinal swelling or increased thickness • Secondly, these patients may have preexisting retinal thinning that creates a falsely normal OCT

  27. Limitations • Small number of Type 1 diabetics, results may not generalize • Treated vs. untreated patients not controlled for and comparison between groups was not made

  28. In Conclusion • Fluorescein is still a useful clinical tool for assessment of leakage and guiding treatment • Although OCT is a less invasive testing modality for detection of DME, up to 1/3rd of patients with active leakage will be missed • OCT not surrogate for clinical exam or FA and cannot be used as a guide for placement of laser photocoagulation

  29. Acknowledgements • Rohan J. Shah, M.D. • Franco Recchia, M.D.

More Related